The association of a novel haplotype in the dopamine transporter with preschool age posttraumatic stress disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 4, 2013, Pages 236-243

  Drury, Stacy S ^a   Brett, Zoë H ^a   Henry, Caitlin ^a   Scheeringa, Michael ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; CHILD; GENETIC ASSOCIATION; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NEUROTRANSMISSION; POSTTRAUMATIC STRESS DISORDER; PRESCHOOL CHILD; RACE; SEMI STRUCTURED INTERVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ALLELES; CHILD; CHILD, PRESCHOOL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MINISATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84878227405     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0072     Document Type: Article

References (69)

1. Abraham A, Cunningham C, Lattal M: Methyphenidate enhances extinction of contextual fear. Learn Mem 19:67-72, 2012.
2. Aupperle R, Allard C, Grimes E, Simmons A, Flagan T, Behrooznia M, Cissell S, Twamley E, Thorp S, Norman S, Paulus M, Stein M: Dorsolateral prefrontal cortex activation during emotional anticipation and neuropsychological performance in posttraumatic stress disorder. Arch Gen Psychiatry 69:360-371, 2012.
3. Bailey JN, Goenjian AK, Noble EP, Walling DP, Ritchie T, Goenjian HA: PTSD and dopaminergic genes, DRD2 and DAT, in multigenerational families exposed to the Spitak earthquake. Psychiatry Res 178:507-510, 2010.
4. Bar-Haim Y, Holoshitz Y, Eldar S, Frenkel TI, Muller D, Charney DS, Pine DS, Fox NA, Wald I: Life-threatening danger and suppression of attention bias to threat. Am J Psychiatry 167:694-698, 2010.
5. Binder E, Bradley R, Kiu W, Epstein M, Deveau T, Mercer K, Tang Y, Gillespie C, Heim C, Nemeroff C, Schwartz A, Cubells J, Ressler K: Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299:1291-1305, 2008.
6. Boscarino J, Erlich P, Hoffman S, Rukstalis M, Stewart W: Association of FKBP5, COMT and CHRNA5 polymorphisms with PTSD among outpatients at risk for PTSD. Psychiatry Res 188: 173-174, 2011.
7. Boscarino J, Erlich P, Hoffman S, Zhang X: Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: Implications for neuropsychiatric research and treatment. Neuropsychiatr Dis Treat 8:131-139, 2012.
8. Bryant R, Harvey A: Attentional bias in posttraumatic stress disorder. J Trauma Stress 10:635-644, 1997.
9. Chang S-C, Koenen KC, Galea S, Aiello AE, Soliven R, Wildman DE, Uddin M: Molecular variation at the SLC6A3 locus predicts lifetime risk of PTSD in the Detroit Neighborhood Health Study. PLos ONE 7:e39184, 2012.
10. Cheon K, Ryu Y, Kim J, Cho D: The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: Relating to treatment response to methylphenidate. Eur Neuropsychopharmacol 15:95-101, 2005.
11. Cohen J: Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 49:414-430, 2010.
12. Comings D, Muhleman D, Gysin R: Dopamine D2 (DRD2) gene and susceptibility to posttraumatic stress disorder: A study and a replication. Biol Psychiatry 40:368-372, 1996.
13. Cornelis M, Nugent N, Amstadter A, Koenen K: Genetics of posttraumatic stress disorder: Review and recommendations for genomewide association studies. Curr Psychiatry Rep 12:313-326, 2010.
14. Dalgleish T, Moradi A, Taghavi M, Neshat-doost H, Yule W: An experimental investigation of hypervigilance for threat in children and adolescents with post-traumatic stress disorder. Psychol Med 31:541-547, 2001.
15. De Bellis MD, Hooper SR, Spratt EG, Woolley DP: Neuropsychological findings in childhood neglect and their relationships to pediatric PTSD. J Int Neuropsychol Soc 15:868-878, 2009.
16. Diamond A: Consequences of variations in genes that affect dopamine in prefrontal cortex. Cereb Cortex 17:i161-170, 2007.
17. Diamond A, Briand L, Fossella J, Gehlbach L: Genetic and neurochemicl modulation of prefrontal cognitive functions in children. Am J Psychiatry 161:125-132, 2004.
18. Drury S, Theall K, Keats B, Scheeringa M: The role of the dopamine transporter (DAT) in the development of PTSD in preschool children. J Trauma Stress 22:534-539, 2009.
19. Egger H, Erkanli A, Keeler G, Potts E, Walter B, Angold A: Testretest reliability of the Preschool Age Psychiatric Assessment (PAPA). J Am Acad Child Adolesc Psychiatry 45:538-549, 2006.
20. Ehlers A, Clark D: A cognitive model of posttraumatic stress disorder. Behav Res Ther 38:319-345, 2000.
21. Enter D, Colzato L, Roelofs K: Dopamine transporter polymorphisms affect social approach-avoidance tendencies. Genes Brain Behav 11:671-676, 2012.
22. Feng Y, Wigg K, Makkar R, Ickowicz A, Pathare T, Tannock R, Roberts W, Malone M, Kennedy JL, Schachar R, Barr CL: Sequence variation in the 30-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). Am J Med Genet B Neuropsychiatr Genet 139B:1-6, 2005.
23. Froelich T, Epstein J, Nick T, Melguizo Castro M, Stein M, Brinkman M, Graham A, Langberg J, Kahn R: Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 50:1129-1139, 2011.
24. Gelernter J, Southwick S, Goodson S, Morgan A, Nagy L, Charney D. No association between D2 dopamine receptor (DRD2) "A" system alleles, or DRD2 haplotypes, and posttraumatic stress disorder. Biol Psychiatry 45:620-625, 1999.
25. Geuze E, Vermetten E, Ruf M, de Kloet CS, Westenberg HGM: Neural correlates of associative learning and memory in veterans with posttraumatic stress disorder. J Psychiatr Res 42:659-669, 2008.
26. Goenjian A, Bailey J, Walling D, Steinberg A, Schmidt D, DandekarU, Noble E: Association of TPH1, TPH2, and 5HTTLPR with PTSD and depressive symptoms. J Affect Disord 140:244-252, 2012.
27. Goldstein L, Rasmusson A, Bunney B, Roth R. Dopamine betahydroxylase (DBH) activity and prefrontal cortical monoamine response to psychological stress in the rat. J Neurosci 16:1087-1089, 2007.
28. Gunnar MR, Quevedo KM: Early care experiences and HPA axis regulation in children: a mechanism for later trauma vulnerability. In: Progress in Brain Research. Vol. 167 Elsevier, 2007, pp. 137-149.
29. Hauschildt M, Peters MJV, Moritz S, Jelinek L: Heart rate variability in response to affective scenes in posttraumatic stress disorder. Biol Psychology 88:215-222, 2011.
30. Heils A, Treufel A, Petri S, Stober G, Riederer P: Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624, 1996.
31. Heinz A, Goldman D, Jones D, Palmour R, Hommer D, Gorey J, Lee K, Linnoila M, Weinberger D: Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133-138, 2000.
32. Hopper JW, Spinazzola J, Simpson WB, van der Kolk BA: Preliminary evidence of parasympathetic influence on basal heart rate in posttraumatic stress disorder. J Psychosom Res 60:83-90, 2006.
33. Hutchison K, Stallings M, McGeary J, Bryan A: Population stratification in the candidate gene study: fatal threat or red herring? Psychol Bull 130:66-79, 2005.
34. Joober R, Grizenko N, Sengupta S, Amor LB, Schmitz N, Schwartz G, Karama S, Lageix P, Fathalli F, Torkaman-Zehi A, Stepanian MT. Dopamine transporter 3[prime]-UTR VNTR genotype and ADHD: A pharmaco-behavioural genetic study with methylphenidate. Neuropsychopharmacology 32:1370-1376, 2006.
35. Kilpatrick D, Koenen K, Ruggiero K, Acierno R, Galea S, Resnick H, Roitzsch J, Boyle J, Gelernter J: The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry 164:1693-1699, 2007.
36. Kimble M, Kaloupek D, Kaufman M, Deldin P: Stimulus novelty differentially affects attentional allocation in PTSD. Biol Psychiatry 47:880-890, 2000.
37. Koenen K: Genetics and posttraumatic stress disorder: Review and recommendations for future studies. J Trauma Stress 20:737-750, 2007.
38. Koenen KC, Aiello A, Bakshis E, Amstadter A, Ruggiero K, Acierno R, Kilpatrick D, Gelernter J, Galea S: Modification of the association between the serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment. Am J Epidemiol 169:704-711, 2009.
39. Koenen KC, Uddin M, Chang S-C, Aiello AE, Wildman DE, Goldmann E, Galea S: SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depress Anxiety 28:639-647, 2011.
40. Kolassa I, Ertl V, Eckart M, Glochner F, Kolassa S, Papassotiropoulos A, de Quervain D, Elbert T: Association study of trauma load and SLC6A4 promoter polymorphism in PTSD: Evidence from survivors of the Rwanda genocide. J Clin Psychiatry 71:543-547, 2010.
41. Lee H, Lee M, Kang R, Kim H, Kim S, Kee B, Kim Y, Kim Y, Kim J, Yeon B, Oh K, Oh B, Yoon J, Lee C, Jung H, Chee I, Paik I: Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety 21:135-139, 2006.
42. Madras B, Miller G, Fishman A. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1397-1409, 2006.
43. Meiser-Stedman R: Towards a cognitive-behavioral model of PTSD in children and adolescents. Clin Child Fam Psychol Rev 5:217-232, 2002.
44. Michelhaugh S, Fiskerstrand C, Lovejoy E, Bannon M, Quinn J: The dopamine transporter gene (SLC6A3) variable number tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 79:1033-1038, 2001.
45. Min Kang A, Palmatier M, Kidd K. Global variation of a 40-bp VNTR in the 3¢-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 46:151-160, 1999.
46. Ouellet-Morin I, Wigg K, Feng Y, Dionne G, Robaey P, Brendgen M, Vitaro F, Simard L, Schachar R, Tremblay RE, Pérusse D, Boivin M, Barr CL: Association of the dopamine transporter gene and ADHD symptoms in a Canadian population-based sample of sameage twins. Am J Med Genet B Neuropsychiatr Genet 147B:1442-1449, 2008.
47. Pietrzak RH, Galea S, Southwick SM, Gelernter J: Examining the relation between the serotonin transporter 5-HTTPLR genotype x trauma exposure interaction on a contemporary phenotypic model of posttraumatic stress symptomatology: A pilot study. J Affect Disord Nov 23. pii: S0165-0327(12)00737- 9. doi: 10.1016/j.jad.2012.11.003. [Epub ahead of print] 2012.
48. Pinsonneault JK, Han DD, Burdick KE, Kataki M, Bertolino A, Malhotra AK, Gu HH, Sadee W: Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Neuropsychopharmacology 36:1644-1655, 2011.
49. Purper-Ouakil D, Wohl M, Mouren M, Verpillat P, Adès J, Gorwood P: Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr Genet 15:53-59, 2005.
50. Roessner V, Sagvolden T, DasBanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N: Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/ hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type. Neuroscience 167:1183-1191, 2010.
51. Sack W, Clarke G, Seeley J: Posttraumatic stress disorders across two generations of Cambodian refugees. J Am Acad Child Adolesc Psychiatry 34:1160-1166, 1995.
52. Schulz-Heik RJ, Schaer M, Eliez S, Hallmayer JF, Lin X, Kaloupek DG, Woodward SH. Catechol-O-methyltransferase Val158Met polymorphism moderates anterior cingulate volume in posttraumatic stress disorder. Biol Psychiatry 70:1091-1096, 2011.
53. Segman R, Cooper-Kazaz R, Macciardi F, Goltser T, Halfon Y, Dobroboski T: Association between the dopamine transporter gene and post-traumatic stress disorder. Mol Psychiatry 7:903-907, 2002.
54. Segman R, McInerney S, Macciardi F, Lasko N, Orra S, Pitman R: Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: A functional MRI study. Biol Psychiatry 40:368-372, 2000.
55. Shook D, Brady C, Lee PS, Kenealy L, Murphy ER, Gaillard WD, VanMeter JW, Cook EH, Stein M, Vaidya CJ. Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls. Am J Med Genet Part B: Neuropsychiatr Genet 156:28-35, 2011.
56. Skelton K, Ressler K, Norrholm S, Jovanovic T, Bradley-Davino B. PTSD and gene variants: New pathways and new thinking. Neuropsychopharmacology 62:628-637, 2012.
57. Stein M, Jang K, Taylor S, Vernon P, Livesly WJ: Genetic and environmental influences on trauma exposure and posttraumatic stress disorder: A twin study. Am J Psychiatry 159:1675-1681, 2002.
58. Szobot CM, Roman T, Hutz MH, Genro JP, Shih MC, Hoexter MQ, Júnior N, Pechansky F, Bressan RA, Rohde LAP: Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity. Synapse 65:154-159, 2011.
59. True W, Rice J, Eisen S, Heath A, Goldberg J, Lyons M, Nowak J. Twin study of genetic and environmental contributions to liability for symptoms of posttraumatic stress symptoms. Arch Gen Psychiatry 50:257-264, 1993.
60. Valente NLM, Vallada H, Cordeiro Q, Miguita K, Bressan RA, Andreoli SB, Mari JJ, Mello MF: Candidate-gene approach in posttraumatic stress disorder after urban violence: association analysis of the genes encoding serotonin transporter, dopamine transporter, and BDNF. J Mol Neurosci 44:59-67, 2011.
61. van de Giessen EM, de Win MML, Tanck MWT, van den Brink W, Baas F, Booij J: Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 50:45-52, 2009.
62. Van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin RM, Innis RB, Gelernter J. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 Gene. J Nucl Med 46:745-751, 2005.
63. Vermetten E, Bremner J: Circuits and systems in stress: II. Applications to neurobiology and treatment in posttraumatic stress disorder. Depress Anxiety 16:14-38, 2002.
64. Voisey J, Swagell C, Hughes I, Morris C, van Daal A, Noble E, Kann B, Heslop K, Hons, McD Young R, Lawford B: The DRD2 gene 957C T polymorphism is associated with posttraumatic stress disorder in war veterans. Depress Anxiety 26:28-33, 2009.
65. Wang Z, Baker DG, Harrer J, Hamner M, Price M, Amstadter A: The relationship between combat-related posttraumatic stress disorder and the 5-HTTLPR/rs25531 polymorphism. Depress Anxiety 28:1067-1073, 2011.
66. Xian H, Chantarujikapong S, Scherrer J, Eisen SL, MJ, Goldberg J, Tsuang M, True WR: Genetic and environmental influences on PTSD, alcohol and drug dependence in twin pairs. Drug Alcohol Depend 61:95-102, 2000.
67. Xie P, Kranzler H, Poling J, Stein M, Anton R, Brady K, Weiss R, Farrer L, Gelernter J: Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry 66:1201-1209, 2009.
68. Xie P, Kranzler H, Poling J, Stein M, Anton R, Farrer L, Gelernter J: Interaction of FKBP5 with childhood adversity on risk for posttraumatic stress disorder. Neuropsychopharmacology 35:1684-1692, 2010.
69. Yehuda R, Halligan S, Beirer L: Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring. J Psychiatr Res 35:261-270, 2001.